Stanley C. Erck, President and CEO, U.S. biotechnology company Novavax, is soon to visit SK Bioscience’s vaccine plant, L House, in Andong, North Gyeongsang Province to discuss local production of Novavax’s Covid-19 vaccine. The two companies signed a technology transfer agreement in August last year to roll out 40 million doses of Novavax’s Covid-19 vaccine in Korea.

[ⓒ Pulse by Maeil Business Newspaper & mk.co.kr, All rights reserved]